Daxor Corporation

NasdaqCM:DXR Rapport sur les actions

Capitalisation boursière : US$43.5m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Daxor Bilan de santé

Santé financière contrôle des critères 2/6

Daxor has a total shareholder equity of $34.0M and total debt of $755.7K, which brings its debt-to-equity ratio to 2.2%. Its total assets and total liabilities are $34.9M and $858.8K respectively.

Informations clés

2.2%

Ratio d'endettement

US$755.66k

Dette

Ratio de couverture des intérêtsn/a
Argent liquiden/a
Fonds propresUS$34.01m
Total du passifUS$858.76k
Total des actifsUS$34.87m

Mises à jour récentes de la santé financière

Recent updates

Daxor reports Q2 results

Aug 25

Daxor partners with Medaxiom to advance awareness of blood volume diagnostic

Jul 21

Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

Mar 08
Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Feb 27
A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Analyse de la situation financière

Passif à court terme: DXR's short term assets ($25.9K) do not cover its short term liabilities ($103.1K).

Passif à long terme: DXR's short term assets ($25.9K) do not cover its long term liabilities ($755.7K).


Historique et analyse du ratio d'endettement

Niveau d'endettement: DXR's net debt to equity ratio (2.2%) is considered satisfactory.

Réduire la dette: DXR's debt to equity ratio has reduced from 34.1% to 2.2% over the past 5 years.

Couverture de la dette: DXR's operating cash flow is negative, therefore debt is not well covered.

Couverture des intérêts: Insufficient data to determine if DXR's interest payments on its debt are well covered by EBIT.


Bilan


Découvrir des entreprises saines